LIVZON PHARMA
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1985-01-26
- Employees
- 8.9K
- Market Cap
- -
- Website
- http://www.livzon.com.cn
- Introduction
The company was founded in January 1985. It is a comprehensive pharmaceutical group company integrating R&D, production and sales of pharmaceutical products, and is an A+H listed company. The company regards R&D innovation as the cornerstone of sustainable development, and continues to pay attention to new molecules and cutting-edge technologies in the globa...
Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection
- First Posted Date
- 2016-07-18
- Last Posted Date
- 2016-07-18
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT02835560
Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSH
- First Posted Date
- 2014-12-04
- Last Posted Date
- 2014-12-08
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 180
- Registration Number
- NCT02307994
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, China
Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2010-04-21
- Last Posted Date
- 2010-04-21
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 330
- Registration Number
- NCT01107938
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-08-06
- Last Posted Date
- 2009-08-06
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 235
- Registration Number
- NCT00953381
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)
- First Posted Date
- 2009-08-06
- Last Posted Date
- 2009-08-06
- Lead Sponsor
- Livzon Pharmaceutical Group Inc.
- Target Recruit Count
- 496
- Registration Number
- NCT00952978
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
© Copyright 2024. All Rights Reserved by MedPath